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ABSTRACT
Objective: The objective of the study was to assess cognitive performance differences, if any, among primary open-angle glaucoma (POAG) patients, 
normal-tension glaucoma (NTG) patients, and healthy control (C) subjects.
Methods: 60 age and sex-matched subjects (20 POAG, 20 NTG, and 20 C subjects) were included in this study. Following routine ophthalmological 
examination the cognitive performance of all participants, detailed neurological examinations, including the mini-mental state examination (MMSE), 
were done.
Results: The mean retinal nerve fiber layer thicknesses were significantly different among the groups in the POAG, NTG, and C subjects, respectively 
(p<0.001). MMSE scores were 24.1±2.4, 25.2±3.8, and 28.9±0.9 in the POAG, NTG, and controls groups, respectively. There were significant differences 
among the three groups (p<0.001). Moreover, there were significant differences between the NTG and controls groups (p<0.001), and between the 
POAG and controls groups (p<0.001).
Conclusions: The overlapping pathogenesis of glaucoma and neurodegenerative disorders cause deterioration in cognitive performance. Decreased 
values of MMSE scores in POAG and NTG patients compared to the scores of healthy controls suggest a detailed neurological examination of glaucoma 
patients.
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INTRODUCTION
Glaucoma, the second chronic cause of blindness in the world, 
is featured by a gradual loss of retinal ganglion cells (RGCs), 
atrophy of optic nerve and visual field defects. Primary open angle 
glaucoma (POAG) forms the main area of research nowadays where 
the important risk factor is elevated intraocular pressure (IOP). 
Another subset of open-angle glaucoma is normal tension glaucoma 
(NTG) in which there is optic nerve degeneration without elevation 
of IOP [1].
With a growing old population, people are at more risk of visual 
loss caused by aging process and dementia. Dementia is a gradual 
neurodegenerative disease featured by cognitive dysfunction, memory 
impairment, personality changes, and behavioral disturbances. 
Alzheimer dementia (AD) may be more frequent among glaucoma 
patients which are attributed to common genetic risk factors and 
similar pathological changes in the optic nerves. A study has shown 
the causal relationship of decreased cerebrospinal fluid pressure 
(CSFP) in patients with the AD. The results by Mandas et al. showed 
that elevated IOP, reduced CSFP, or both could lead to an increased 
translaminar pressure difference, following glaucomatous optic nerve 
damage [2,3].
There are few studies showing associations between age-related 
degenerative eye diseases including cataract, glaucoma, age-related 
macular degeneration (AMD), and dementia. Only a few studies 
analyzed the potential link between glaucoma and cognitive function 
impairment and found controversial results [4,5].
Till now, the mini-mental state examination (MMSE) is the best-studied 
method of analyzing cognitive impairment. This test is scored of 30, a 
score of 24 or less suggest dementia [6,7].
With the above tools of cognitive assessment, the aim of our study was 
to determine if there are differences among the POAG, NTG, and healthy 
controls in terms of cognitive skills.
METHODS
The research followed the tenets of the Declaration of Helsinki 
and consent of the Ethical Committee was obtained for the study 
protocol. All patients provided written informed consent before 
participation. The study sample comprised three groups between age 
45 and 65 years: Group I - 20 age and sex-matched healthy controls, 
Groups II - 20 patients with NTG, and Group ІІІ - 20 patients with POAG.
Inclusion  criteria  for  Group  IІІ  (POAG)  are:  IOP  >21 mmHg  without 
treatment, optic disc changes with neuro-retinal rim notching, optic 
disc excavation, vertical or horizontal cup to disk (C/D) ratio >0.5 or C/D 
asymmetry between 2 eyes >0.2, peripapillary  splinter hemorrhages, 
visual field outside normal limits on Humphrey automated perimetry 
on three perimetry readings, and all angles (360°) open on gonioscopy.
Inclusion criteria for Group ІІ (NTG) are same as for POAG except IOP 
ranging between 10 and 21 mmHg.
Exclusion criteria include patients with AMD, secondary causes of 
glaucoma, hazy media, optic neuritis, any disease involving the macula, 
retina, or visual pathway, high myopia (>6 dioptre), previous intraocular 
surgery and on drugs known to cause optic neuropathy, and patients 
with diabetes mellitus and hypertension.
All subjects in this study underwent an ophthalmological examination 
including visual acuity with Snellen chart, IOP measurement using 
Goldmann’s applanation tonometer, measurement of central corneal 
thickness (CCT) by an optical pachymetry, gonioscopy, and fundus 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i10.27068
Research Article
550
Asian J Pharm Clin Res, Vol 11, Issue 10, 2018, 549-551
 Banerjee and Khurana 
examination for glaucoma diagnosis and grouping. Neurological 
examination including motor, sensory and cerebellar system 
examination was done in all the subjects following which the concerned 
investigation of our research that is a cognitive function for scanning of 
dementia in these subjects was carried out using MMSE.
In MMSE orientation, attention, memory, language, and shape copying 
are assessed. The maximum score is 30, and the cutoff value as was 
determined by Gungen and his associates in 2002 to be 24 [8]. Long-
term memory, short-term memory, attention span, calculation, naming 
of items, performance of task in three steps, reading, writing, and 
assembling abilities were all measured in MMSE. A little training is 
required before the execution of the test, and it usually takes about 
10 min and has vast medical acceptance. In clinical practice, a rough 
rule of thumb is practiced that patients with mild dementia generally 
seen having a score of 18–26 of 30, while those with moderate 
dementia a score of 10–18, and subjects with severe dementia a score 
of <10. At scores above the level of 24, the MMSE lacks sensitivity for 
the diagnosis of mild dementia, and other assessments are needed. 
The MMSE focuses on memory, attention, construction, and orientation 
domains.
The statistical data analysis was performed using software SPSS Version 
20.0 (SPSS, Inc., IBM Corp., USA). All variables were defined by methods 
of descriptive statistics. The analysis of the quantitative variables 
included calculation of the mean and standard deviation (×[SD]). 
One-way analysis of variance was used to compare the differences 
among the three groups for each variable. Pairwise comparison of the 
MMSE scores between the controls and NTG and POAG patients were 




(POAG) were 51.6±5.25, 53.45±4.88, and 51.75±6.07 years, respectively. 
There were no significant differences with respect to age among the 
groups (p=0.32). Of 20 NTG patients, 55% were males and 45% were 
females, in POAG patients 65% were males and 35% were females, 
whereas in control group 60% were males and 40% were females. The 
mean basal  value of  IOP  in Groups  І  and  ІІ was within normal  range 
and comparable; however, the mean basal IOP was significantly higher 
(26.3±1.75) in Group ІІІ (p<0.000).
Table 1 shows significant statistical differences in CCT among the 
three groups. While comparing the groups pairwise, we found the 
statistically significant difference between controls and NTG (p=0.004) 
along with a high degree of significant difference between controls and 
POAG (p<0.001). The mean retinal nerve fiber layer (RNFL) thickness 
measurements among three groups also found to be statistically 
significant. Further on comparing GroupWise significant differences 
were found between NTG and POAG (p=0.021) and the NTG and control 
groups (p<0.002).
The MMSE scores, when compared together, the differences among the 
three groups were statistically significant (p<0.001). On comparing the 
scores GroupWise individually, we could find a significant difference 
between controls and NTG (p<0.001) and between controls and POAG 
(p<0.001), with no such differences between NTG and POAG groups.
DISCUSSION
The present study was done with the aim to find out any differences 
in cognitive status using the MMSE scoring system with respect to age 
and sex-matched subjects among the three groups (controls, NTG, and 
POAG). The relationship between cognitive and visual decline has been 
an arguable topic nowadays. The progress of dementia determined by 
lower MMSE scores depends on its pathogenesis while as we know, 
glaucoma is also a neurodegenerative disease.
In a previous study, the incidence of glaucoma was seen to be 26% in 
Alzheimer’s Disease while only 5% in controls [8]. Later in another 
study conducted by Tamura et al., glaucoma was seen prevalent in 
24% of Alzheimer’s patients. The study proposed that the lower ocular 
perfusion pressure leads to glaucomatous optic neuropathy which 
is seen in the early stages of Alzheimer’s disease [9]. Yochim et al. 
concluded cognitive dysfunction in glaucoma, with number amounting 
to 44% [10]. Hagerman et al. also found that 32% of patients with low 
vision had impaired cognitive function [11].
MMSE score is used to evaluate the cognitive function of a person 
and screening of dementia with 30 being the maximum score. More 
accurate and comprehensive assessment could have been done by 
Montreal cognitive assessment (MoCA), where attention, language 
skills, and visuospatial processing were included [12]. In our study, 
we confined our three groups (controls, NTG, and POAG) only to the 
MMSE scoring system, since the educational level was poor, we could 
not include MoCA test. In our study, significant statistical differences 
were observed among the three groups. This is in accordance with the 
findings reported by Jefferis et al. [13]. The mean thickness of RNFL 
and CCT values in both the glaucoma groups were thinner as compared 
to controls. The results were consistent with the previous study [14].
Researchers have shown that glaucoma has few similar pathogenetic 
causes as that of Antithyroid drugs (ATD), which is the most common cause 
of dementia when both are related to aging. Recently, Yoneda et al. depicted 
that beta-amyloid and tau (neurofibrillary tangles) found in ATD pathology, 
do play important roles in glaucoma pathology. They also observed lower 
levels of beta-amyloid and a higher level of tau in the vitreous of glaucoma 
patients when compared with control group. In addition, it was found 
that beta-amyloid accumulates in the RGCs of rats with glaucoma induced 
for experimental purposes [15-18]. Thus, the study brought to us the 
hypothesis that lower cognitive scores were expected in glaucoma patients.





to evaluate the cognitive status of the patients, such as the MoCA.
CONCLUSION
Since glaucoma and the dementia group of diseases possess same 
neurodegenerative pathogenesis affecting cognitive impairment, 
our findings support our hypothesis. Thus, it becomes necessary for 
an ophthalmologist to evaluate the cognitive status of the glaucoma 
patients to prevent early progression of dementia in the patients.
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Table 1: Comparison of the mean CCT, RNFL, and MMSE among 
the controls, NTG, and POAG groups







CCT 556.9±22.4 521.0±25.8 535.6±28.7 <0.00*̽
RNFL 90.8±2.4 76.62±7.8 84.6±6.2 <0.00*̽
MMSE 28.9±0.9 25.2±3.8 24.1±2.4 <0.00*̽
CCT: Central corneal thickness, RNFL: Retinal nerve fiber layer, 
MMSE: Mini-mental state examination. ̽Significant value. NTG: Normal-tension 
glaucoma, POAG: Primary open-angle glaucoma
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